Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
18/06/202006:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/06/202006:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/06/202006:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/06/202006:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/06/202006:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/06/202008:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/06/202021:17PR Newswire (US)Two Science Publications Highlight Potential of REGN-COV2 Anti-Viral Antibody Cocktail to Protect Against SARS-CoV-2 Escape M...NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/06/202021:00PR Newswire (US)Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/06/202014:59PR Newswire (US)Regeneron Collaborations on Dupixent® (dupilumab) Highlighted During Sanofi R&D Investor EventNASDAQ:REGNRegeneron Pharmaceuticals Inc
11/06/202006:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/06/202000:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:REGNRegeneron Pharmaceuticals Inc
10/06/202023:00PR Newswire (US)Regeneron Recognized as Healthcare Sector Leader on "The Civic 50" List of the Most Community-Minded Companies in the United ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
10/06/202006:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/06/202023:00PR Newswire (US)Regeneron Announces Virtual-Only Format for 2020 Annual Meeting of ShareholdersNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/06/202022:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/06/202006:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/06/202021:00PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/06/202006:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
02/06/202006:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
02/06/202006:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
01/06/202021:00PR Newswire (US)Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based TreatmentsNASDAQ:REGNRegeneron Pharmaceuticals Inc
30/05/202006:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
30/05/202006:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
30/05/202006:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
30/05/202006:01PR Newswire (US)Regeneron Completes Secondary Offering of Common Stock Held by SanofiNASDAQ:REGNRegeneron Pharmaceuticals Inc
29/05/202022:00PR Newswire (US)Libtayo® (cemiplimab-rwlc) Longer-term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ASCO 2020 Show Dur...NASDAQ:REGNRegeneron Pharmaceuticals Inc
29/05/202005:51Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:REGNRegeneron Pharmaceuticals Inc
28/05/202017:02Dow Jones NewsSanofi to Offload Stake in Regeneron -- WSJNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/05/202021:42Dow Jones NewsSanofi to Sell Regeneron Shares Worth $11.1 Billion to Fund OverhaulNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/05/202015:44Dow Jones NewsSanofi to Raise Up to $11.7 Billion in Regeneron Stake SaleNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN